Alerts will be sent to your verified email
Verify EmailNone
|
Agilus Diagnostics
|
Dr. Reddy's Lab
|
Concord Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.76 % | 15.68 % | 2.78 % |
|
5yr average Equity Multiplier
|
1.31 | 1.41 | 1.87 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.74 | 0.84 |
|
5yr Avg Net Profit Margin
|
13.54 % | 15.18 % | 1.59 % |
|
Price to Book
|
n/a | 2.87 | 2.25 |
|
P/E
|
n/a | 25.92 | 102.89 |
|
5yr Avg Cash Conversion Cycle
|
-76.03 Days | 74.48 Days | 233.27 Days |
|
Inventory Days
|
12.61 Days | 76.14 Days | 152.22 Days |
|
Days Receivable
|
40.18 Days | 95.44 Days | 106.22 Days |
|
Days Payable
|
133.32 Days | 102.6 Days | 74.71 Days |
|
5yr Average Interest Coverage Ratio
|
16.11 | 35.66 | 1.69 |
|
5yr Avg ROCE
|
8.69 % | 21.82 % | 8.41 % |
|
5yr Avg Operating Profit Margin
|
18.66 % | 23.61 % | 9.1 % |
|
5 yr average Debt to Equity
|
0.0 | 0.12 | 0.55 |
|
5yr CAGR Net Profit
|
-5.76 % | 23.71 % | -26.55 % |
|
5yr Average Return on Assets
|
7.77 % | 11.24 % | 1.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 26.63 % | 54.39 % |
|
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | -0.07 % | 2.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 3.32 % | 0.0 |
|
Agilus Diagnostics
|
Dr. Reddy's Lab
|
Concord Drugs
|
|---|